Envestnet Asset Management’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-34
| Closed | -$1K | – | 3059 |
|
|
2017
Q3 | $1K | Hold |
34
| – | – | ﹤0.01% | 2895 |
|
|
2017
Q2 | $1K | Sell |
34
-1,406
| -98% | -$34.6K | ﹤0.01% | 3036 |
|
|
2017
Q1 | $34K | Sell |
1,440
-470
| -25% | -$11.6K | ﹤0.01% | 2547 |
|
|
2016
Q4 | $48K | Sell |
1,910
-171
| -8% | -$4.32K | ﹤0.01% | 2463 |
|
|
2016
Q3 | $58K | Sell |
2,081
-343
| -14% | -$8.79K | ﹤0.01% | 2547 |
|
|
2016
Q2 | $60K | Buy |
2,424
+265
| +12% | +$6.58K | ﹤0.01% | 2659 |
|
|
2016
Q1 | $48K | Sell |
2,159
-6,514
| -75% | -$173K | ﹤0.01% | 2740 |
|
|
2015
Q4 | $304K | Sell |
8,673
-294
| -3% | -$9.21K | ﹤0.01% | 1830 |
|
|
2015
Q3 | $255K | Sell |
8,967
-645
| -7% | -$21.7K | ﹤0.01% | 1905 |
|
|
2015
Q2 | $320K | Buy |
9,612
+212
| +2% | +$6.51K | ﹤0.01% | 1920 |
|
|
2015
Q1 | $265K | Buy |
9,400
+5,961
| +173% | +$148K | ﹤0.01% | 1835 |
|
|
2014
Q4 | $71K | Sell |
3,439
-572
| -14% | -$13.6K | ﹤0.01% | 1285 |
|
|
2014
Q3 | $98K | Buy |
4,011
+2,287
| +133% | +$60.6K | ﹤0.01% | 1302 |
|
|
2014
Q2 | $49K | Buy |
1,724
+1,678
| +3,648% | +$46.7K | ﹤0.01% | 1447 |
|
|
2014
Q1 | $1K | Sell |
46
-609
| -93% | -$15K | ﹤0.01% | 2499 |
|
|
2013
Q4 | $14K | Hold |
655
| – | – | ﹤0.01% | 1633 |
|
|
2013
Q3 | $9K | Hold |
655
| – | – | ﹤0.01% | 1765 |
|
|
2013
Q2 | $9K | Buy |
+655
| New | +$9.28K | ﹤0.01% | 1724 |
|
Envestnet Asset Management's PMC Position: Q4 2017 in Review
Envestnet Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 34 shares — an estimated $1K sold.
Envestnet Asset Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $320K in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Envestnet Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Envestnet Asset Management sold 34 PharMerica Corporation shares in Q4 2017, an estimated $1K.
- Envestnet Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Envestnet Asset Management's PharMerica Corporation position peaked at $320K in Q2 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Envestnet Asset Management's 13F filing for Q4 2017, filed 20 Feb 2018.